149503-79-7 Usage
Definition
ChEBI: A member of the class of pyrrolidin-2-ones that is pyrrolidin-2-one in which the 3-pro-S-hydrogen is substituted by a 2-methoxy-2-oxoethyl group, while the 5-pro-S-hydrogen is substituted by a ({4
-[N-(methoxycarbonyl)carbamimidoyl]biphenyl-4-yl}oxy)methyl group. It is an orally active prodrug of fradafiban, a figrinogen receptor antagonist.
Check Digit Verification of cas no
The CAS Registry Mumber 149503-79-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,9,5,0 and 3 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 149503-79:
(8*1)+(7*4)+(6*9)+(5*5)+(4*0)+(3*3)+(2*7)+(1*9)=147
147 % 10 = 7
So 149503-79-7 is a valid CAS Registry Number.
InChI:InChI=1/C23H25N3O6/c1-30-20(27)12-17-11-18(25-22(17)28)13-32-19-9-7-15(8-10-19)14-3-5-16(6-4-14)21(24)26-23(29)31-2/h3-10,17-18H,11-13H2,1-2H3,(H,25,28)(H2,24,26,29)/t17-,18-/m0/s1
149503-79-7Relevant articles and documents
Cyclic imino derivatives, processes for preparing them and pharmaceutical compositions containing these compounds
-
, (2008/06/13)
Cyclic imino derivatives of the formula wherein A, B, E, X1, X2 and Y are as defined herein, the stereoisomers, tautomers, mixtures and addition salts thereof, pharmaceutical compositions containing these compounds and processes for preparing them. The cyclic imino derivatives are useful as inhibitors of cell-cell and cell-matrix interactions, e.g., thrombocyte aggregation.